{"disease":{"id":"tumors-at-all-sites-which-will-receive-radiotherapy","name":"tumors at all sites which will receive radiotherapy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04351204","title":"The MR-Linac Technical Feasibility Protocol","phase":"NA","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"The Netherlands Cancer Institute","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}